Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

BACKGROUND: Bacterial vaginosis (BV) increases HIV risk and adverse reproductive outcomes. Standard-of-care (SOC) for BV are antibiotics; however, cure rates are low. Probiotics for vaginal health may be useful in improving cure and recurrence although the regulatory framework governing probiotics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Happel, Anna-Ursula, Singh, Ravesh, Mitchev, Nireshni, Mlisana, Koleka, Jaspan, Heather B., Barnabas, Shaun L., Passmore, Jo-Ann S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350581/
https://www.ncbi.nlm.nih.gov/pubmed/32650729
http://dx.doi.org/10.1186/s12879-020-05210-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350581/
https://www.ncbi.nlm.nih.gov/pubmed/32650729
http://dx.doi.org/10.1186/s12879-020-05210-4

Ejemplares similares